| Basics |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
|
| IPO Date: |
April 2, 1991 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$75.5B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$4.32 | 1.80%
|
| Avg Daily Range (30 D): |
$10.87 | 1.59%
|
| Avg Daily Range (90 D): |
$9.13 | 1.48%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.67M |
| Avg Daily Volume (30 D): |
.9M |
| Avg Daily Volume (90 D): |
.85M |
| Trade Size |
| Avg Trade Size (Sh.): |
61 |
| Avg Trade Size (Sh.) (30 D): |
21 |
| Avg Trade Size (Sh.) (90 D): |
24 |
| Institutional Trades |
| Total Inst.Trades: |
11,453 |
| Avg Inst. Trade: |
$18.83M |
| Avg Inst. Trade (30 D): |
$46.77M |
| Avg Inst. Trade (90 D): |
$42.99M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$37.02M |
| Avg Closing Trade (30 D): |
$98.3M |
| Avg Closing Trade (90 D): |
$85.18M |
| Avg Closing Volume: |
74.47K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$43.41
|
$14.09
|
$13.24
|
|
Diluted EPS
|
$41.75
|
$13.62
|
$12.81
|
|
Revenue
|
$ 14.25B
|
$ 3.75B
|
$ 3.68B
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ 4.58B
|
$ 1.46B
|
$ 1.39B
|
|
Operating Income / Loss
|
$ 3.69B
|
$ 1.03B
|
$ 1.08B
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 501.3M
|
$ 497.5M
|
$ -1077.4M
|
|
PE Ratio
|
16.99
|
|
|
|
|
|
